We therefore performed a randomized, double-blind, placebo-controlled trial to determine whether use of a short-acting bronchodilator provides a protective effect in patients with COPD undergoing ...

Bronchodilators not only dilate the airway, but they also reduce hyperinflation during exercise and are invaluable in the treatment of COPD. Historically, short-acting beta2-agonists have been one ...

Not studied in patients with acutely deteriorating asthma or COPD. Immediately reevaluate ... treat immediately with an inhaled, short-acting bronchodilator; discontinue Serevent Diskus ...

This pulmonary function test is used to diagnose lung diseases Spirometry, a type of pulmonary function test (PFT), is a ...

Traditionally, COPD management has relied on bronchodilators, pulmonary rehabilitation, steroids, and invasive options like lung transplantation or lung volume reduction surgery, leaving a gap in ...

The right treatment plan can help you control your COPD symptoms and avoid exacerbations (flareups). These include shortness ...

“Alongside our successful Ohtuvayre launch, in the third quarter we initiated two Phase 2 clinical trials: a dose-ranging trial with glycopyrrolate, a long-acting muscarinic antagonist (“LAMA ...

a long-acting muscarinic antagonist (“LAMA”), supporting a nebulized fixed-dose combination program with ensifentrine for the maintenance treatment of COPD, and a trial assessing the efficacy ...

“While it is still very early in the launch, we are extremely encouraged from the initial patient and HCP reports about Ohtuvayre’s potential to improve COPD symptoms regardless of COPD severity. This ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

LONDON and RALEIGH, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces four oral presentations and two posters on ...